Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$4.3 - $7.78 $1,595 - $2,886
371 Added 2.53%
15,034 $80,000
Q4 2022

Feb 10, 2023

SELL
$5.57 - $11.01 $7,118 - $14,070
-1,278 Reduced 8.02%
14,663 $92,000
Q3 2022

Nov 03, 2022

BUY
$5.34 - $12.79 $85,124 - $203,885
15,941 New
15,941 $168,000
Q4 2021

Feb 10, 2022

SELL
$14.59 - $23.26 $875,400 - $1.4 Million
-60,000 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$15.75 - $30.29 $945,000 - $1.82 Million
60,000 New
60,000 $1.43 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $123M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.